DOI:
10.1055/s-00000094
Zeitschrift für Gastroenterologie
LinksClose Window
References
Hoegenauer C, Mahida Y, Stallmach A.
Open-label study to evaluate the pharmacokinetics of fidaxomicin in inflammatory bowel disease patients with Clostridium difficile infection (the PROFILE study): pharmacokinetics analysis.
Journal of Crohn's and Colitis 2017; (Suppl. 01) S276
We do not assume any responsibility for the contents of the web pages of other providers.